Clinical features as potential prognostic factors in patients treated with nivolumab for highly pretreated metastatic gastric cancer: a multicenter retrospective study.

Akihiko SanoMakoto SohdaNobuhiro NakazawaYasunari UbukataKengo KuriyamaAkiharu KimuraNorimichi KogureHisashi HosakaAtsushi NaganumaMasanori SekiguchiKana SaitoKyoichi OgataMakoto SakaiHiroomi OgawaKen ShirabeHiroshi Saeki

Published in: BMC cancer (2022)

The findings of this study suggest that nivolumab may be ineffective for AGC in patients with poor performance status and those with a history of treatment with trastuzumab.

Keyphrases

prognostic factors
small cell lung cancer
epidermal growth factor receptor
cross sectional
clinical trial
risk assessment
combination therapy
replacement therapy
tyrosine kinase